stockportfolio.pro
ADMA Biologics, Inc. Net Income 2011–2025
ADMA Biologics, Inc. (ADMA) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $146.93M | 28.8% | -25.7% |
| FY 2024 | $197.67M | 46.4% | +800.0% |
| FY 2023 | $-28.24M | -10.9% | +57.2% |
| FY 2022 | $-65.90M | -42.8% | +8.0% |
| FY 2021 | $-71.65M | -88.5% | +5.4% |
| FY 2020 | $-75.75M | -179.4% | -56.9% |
| FY 2019 | $-48.28M | -164.5% | +26.6% |
| FY 2018 | $-65.74M | -387.1% | -50.2% |
| FY 2017 | $-43.76M | -192.3% | -124.2% |
| FY 2016 | $-19.52M | -183.1% | -8.6% |
| FY 2015 | $-17.97M | -250.4% | -6.9% |
| FY 2014 | $-16.81M | -284.2% | -8.3% |
| FY 2013 | $-15.53M | -506.2% | -112.7% |
| FY 2012 | $-7.30M | -653.0% | -23.7% |
| FY 2011 | $-5.90M | -775.7% | — |
Source: ADMA Biologics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for ADMA Biologics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeADMA Biologics, Inc. — frequently asked questions
What is ADMA Biologics, Inc.'s net income?
ADMA Biologics, Inc. (ADMA) reported net income of $146.93M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ADMA Biologics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.